This HTML5 document contains 138 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n4https://api.elsevier.com/content/article/PII:S0022347603004463?httpAccept=text/
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1067/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33357593
rdf:type
wikibase:Item
schema:description
מאמר מדעי artykuł naukowy opublikowany 1 listopada 2003 vetenskaplig artikel publicerad den 1 november 2003 wetenschappelijk artikel gepubliceerd op 1 november 2003 bài báo khoa học xuất bản ngày 1 tháng 11, 2003 2003年学术文章 2003年學術文章 2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած im 1. November 2003 veröffentlichter wissenschaftlicher Artikel научная статья опубликованная 1 ноября 2003 г. мақолаи илмӣ videnskabelig artikel offentliggjort den 1. november 2003 artigo científico publicado em 1 de novembro de 2003 vitskapeleg artikkel 2003年學術文章 научна статия, публикувана на 1 ноември 2003 г. مقالة علمية تنشرت ف 1 نونمبر 2003 2003年学术文章 επιστημονικό άρθρο scientific article published on November 1, 2003 artikulong pang-agham مقالة علمية نشرت في نوفمبر 2003 tieteellinen artikkeli 1 Kasım 2003'de yayımlanmış bilimsel makale мақолаи илмӣ scienca artikolo teaduslik artikkel 2003年学术文章 scientific article published on 1 November 2003 научни чланак објављен 1. новембар 2003. 2003年學術文章 სამეცნიერო სტატია maqolai ilmiy научни чланак објављен 1. новембар 2003. vitenskapelig artikkel 2003年の学術論文 mokslinis straipsnis, publikuotas 2003 m. lapkričio 1 d. artikull shkencor i botuar më 1 nëntor 2003 2003年學術文章 tudományos cikk artículo científico publicado el 1 de noviembre de 2003 наукова стаття, опублікована в листопаді 2003 article scientifique publié le 1 novembre 2003 مقالهٔ علمی articolo scientifico pubblicato il 1 novembre 2003 2003 nî ê lūn-bûn vědecký článek publikovaný 1. listopadu 2003 znanstveni članek objavljen 1. november 2003 artigo científico publicado em 1 de novembro de 2003 سائنسی مضمون 2003年學術文章 artículu científicu espublizáu en 2003 ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ naučni članak article scientific artigo científico 2003年学术文章 2003年學術文章 article científic บทความทางวิทยาศาสตร์ 2003 թվականի նոյեմբերին հրատարակված գիտական հոդված artikel ilmiah articol științific vedecký článok publikovaný 1. novembra 2003 2003年学术文章 2003년 논문
p:P577
wds:Q33357593-4B35E5B9-0615-48A6-A42E-33FB0B2CE7A1
wdt:P577
2003-11-01T00:00:00Z
p:P407
wds:Q33357593-B482A0C6-8DA9-42FA-840F-082D2B5C301E
wdt:P407
wd:Q1860
p:P2860
wds:Q33357593-09F66D2E-8F54-432A-9652-08E87D411859 wds:Q33357593-1AD0F604-CC9D-41FB-9A58-E0DB2CC27BA3 wds:Q33357593-1E737319-DD63-4994-A464-4021F50324A0 wds:Q33357593-4A39917E-B9A0-4292-A3C9-15A3F0D841C9 wds:Q33357593-4BA619F8-D53A-4A96-BDB5-36E86A02ED94 wds:Q33357593-678FDA46-835D-4872-A4B0-3D72CC712F4C wds:Q33357593-6CC00F76-30A3-4F37-907B-7DECB1D1D770 wds:Q33357593-839CB7AC-8349-47ED-B55F-CE6B38B496AE wds:Q33357593-8E94E99F-0E68-41C2-8F9D-7C4E63930AE3 wds:Q33357593-982645BD-D962-49B7-844E-F4540998FC4F wds:Q33357593-B42D8C31-1987-418A-8A8B-6F522FF81D53 wds:Q33357593-F4E056E6-430C-4A3C-8CBC-AB13F054D9ED
wdt:P2860
wd:Q33333428 wd:Q47685354 wd:Q33338442 wd:Q33338419 wd:Q33503661 wd:Q74205032 wd:Q33336196 wd:Q33332219 wd:Q77759546 wd:Q74263448 wd:Q43797411 wd:Q33331528
p:P2093
wds:Q33357593-E59E0791-A6CF-422F-85C6-A841093C85F2 wds:Q33357593-CD7B862C-DBA0-4289-B67E-E214D69C485B wds:Q33357593-B8DBA4A1-E8E9-4139-9196-56FD9EB8B2EC
wdt:P2093
Kristi L. Bengtson Russell E. Ware Michael A. Skinner
rdfs:label
Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura
skos:prefLabel
Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura
schema:name
Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura
p:P1476
wds:Q33357593-5EA45D4F-7159-4DCA-9680-D64EB7D7CC3D
wdt:P1476
Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura
p:P304
wds:Q33357593-6F9F10EB-B635-4B35-BCEB-928AD6ECF1C9
wdt:P304
670-673
p:P31
wds:Q33357593-76258E3C-5885-4733-A7C6-5D9E4E8989AD
wdt:P31
wd:Q13442814
p:P921
wds:Q33357593-C3D5333C-932A-4F93-A926-E7252EA6CDCA wds:Q33357593-A919DEBF-4213-4CA3-874A-4FA7AB8E3CBC wds:Q33357593-6F71CFB5-37F8-424A-9586-B4CF30F8628B
wdt:P921
wd:Q3410984 wd:Q585285 wd:Q412323
p:P698
wds:Q33357593-0477E717-4CEC-41FE-B4EB-A5CB0131FDD8
wdtn:P698
n12:14615744
wdt:P698
14615744
p:P1433
wds:Q33357593-10C828F0-919B-4C97-91A0-05E7BB5D548E
p:P953
wds:Q33357593-38313FB8-5228-4330-BFBC-55BADA6F3F34 wds:Q33357593-FBD756BE-AED5-4B2D-9429-EED33AD207BB
wdt:P1433
wd:Q7743611
wdt:P953
n4:plain n4:xml
p:P433
wds:Q33357593-2E0BC016-A209-4D47-AD74-9E2AF13E2BED
p:P478
wds:Q33357593-DCE0328F-EBD2-4547-83D9-31DA4FDB900B
wdt:P433
5
wdt:P478
143
p:P356
wds:Q33357593-9BD21A5C-F1A9-447C-B16B-10815E70C0D6
wdtn:P356
n11:S0022-3476(03)00446-3
wdt:P356
10.1067/S0022-3476(03)00446-3